INOVOTION - Which molecule will stand out ?
  • Drug discovery
    • Efficacy & Toxicity
    • Target Validation
    • Toxicity Assays
  • Personalized Medicine
    • Personalized Medicine
    • Organoids
  • Our technology
    • A Unique In Vivo Technology
    • 3RS
    • F.A.Q.
  • Your benefits
    • FAST
    • SENSITIVE
    • RELIABLE
    • AFFORDABLE
    • 3Rs
    • Summary of Benefits
  • Resources
    • Webinars
    • Publications
    • White Paper
    • Newsletter
    • Posters
    • Request documents
  • News
  • About us
    • History
    • Mission & Vision
    • Customers
    • Partners
    • Legal Notice
    • Privacy Policy
    • Jobs
  • Contact

Close menu

 

Efficacy & Toxicity
Target Validation
Toxicity Assays
Multi Cancer Screening

6 short introductions to our technological platform

Eté 2024 - #1 sur 6 - Inovotion's CAM model - Overview (3) (1)_Page_1
Eté 2024 - #1 sur 6 - Inovotion's CAM model - Overview (3) (1)_Page_2
Eté 2024 - #1 sur 6 - Inovotion's CAM model - Overview (3) (1)_Page_3
Eté 2024 - #1 sur 6 - Inovotion's CAM model - Overview (3) (1)_Page_4
Eté 2024 - #2 sur 6 - Alternative in vivo testing using Inovotion's CAM model visuel (1)_Page_1
Eté 2024 - #2 sur 6 - Alternative in vivo testing using Inovotion's CAM model visuel_Page_2
Eté 2024 - #2 sur 6 - Alternative in vivo testing using Inovotion's CAM model visuel_Page_3
Eté 2024 - #2 sur 6 - Alternative in vivo testing using Inovotion's CAM model visuel_Page_4
Eté 2024 - #3 sur 6 - Efficacy and Toxicity Testing using Inovotion's CAM model visuel_Page_1
Eté 2024 - #3 sur 6 - Efficacy and Toxicity Testing using Inovotion's CAM model visuel_Page_2
Eté 2024 - #3 sur 6 - Efficacy and Toxicity Testing using Inovotion's CAM model visuel_Page_3
Eté 2024 - #3 sur 6 - Efficacy and Toxicity Testing using Inovotion's CAM model visuel_Page_4
Eté 2024 - #4 sur 6 - Target Validation using Inovotion's CAM model (1)_Page_1
Eté 2024 - #4 sur 6 - Target Validation using Inovotion's CAM model (1)_Page_2
Eté 2024 - #4 sur 6 - Target Validation using Inovotion's CAM model (1)_Page_3
Eté 2024 - #4 sur 6 - Target Validation using Inovotion's CAM model (1)_Page_4
Eté 2024 - #5 sur 6 - Biomaterials testing using Inovotion's CAM model_Page_1
Eté 2024 - #5 sur 6 - Biomaterials testing using Inovotion's CAM model_Page_2
Eté 2024 - #5 sur 6 - Biomaterials testing using Inovotion's CAM model_Page_3
Eté 2024 - #5 sur 6 - Biomaterials testing using Inovotion's CAM model_Page_4
Eté 2024 - #6 sur 6 - Organoids for Personalized Medicine using Inovotion's CAM model_Page_1
Eté 2024 - #6 sur 6 - Organoids for Personalized Medicine using Inovotion's CAM model_Page_2
Eté 2024 - #6 sur 6 - Organoids for Personalized Medicine using Inovotion's CAM model_Page_3

News & Events

  • Dec 09

    2025

    INOVOTION was honored to speak at the AFFSSI Connexions

    INOVOTION was honored to speak at the AFFSSI Connexions

  • Dec 08

    2025

    Patient-Derived Tumor Avatars in CAM: Toward Personalized Oncology in Preclinical Models

    Patient-Derived Tumor Avatars in CAM: Toward Personalized Oncology in Preclinical Models

  • Dec 08

    2025

    RNA Therapeutics in Oncology: Validating the CAM Model for In Vivo RNA-Based Studies

    RNA Therapeutics in Oncology: Validating the CAM Model for In Vivo RNA-Based Studies

Contact

https://www.inovotion.com/contact

France : +33 (0)476 549 512
USA : +1 (617) 230-6738

DOWNLOAD
THE BROCHURE

Inovotion logo
INOVOTION SAS 
Biopolis - 5 Avenue du grand sablon - 38700 La Tronche - France
Phone: +33 476 549 512
Fax: +33 476 549 511
Contact us

INOVOTION INC.
185 Alewife Brook Parkway, Suite 210, Cambridge, MA 02138, USA
Phone: +1 (617) 230-6738
Contact us


Newsletter


Our publications

  • Cookie Policy
  • Legal Notice
  • Privacy Policy